124 related articles for article (PubMed ID: 22682117)
1. Risk assessment for cancer-associated thrombosis: what is the best approach?
Khorana AA
Thromb Res; 2012 Apr; 129 Suppl 1():S10-5. PubMed ID: 22682117
[TBL] [Abstract][Full Text] [Related]
2. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
Connolly GC; Khorana AA
Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
[TBL] [Abstract][Full Text] [Related]
3. Accounting for death as a competing risk in cancer-associated thrombosis studies.
Campigotto F; Neuberg D; Zwicker JI
Thromb Res; 2012 Apr; 129 Suppl 1():S85-7. PubMed ID: 22682141
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
5. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A; Russo L
Hamostaseologie; 2012; 32(2):115-25. PubMed ID: 21971578
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
Sud R; Khorana AA
Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment for thrombosis in cancer.
Gomes M; Khorana AA
Semin Thromb Hemost; 2014 Apr; 40(3):319-24. PubMed ID: 24599438
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification for cancer-associated venous thromboembolism.
Connolly GC; Khorana AA
Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
12. Identifying cancer patients at risk for venous thromboembolism.
Sousou T; Khorana A
Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
[TBL] [Abstract][Full Text] [Related]
13. VTE risk assessment in cancer. Who needs prophylaxis and who does not?
Ay C; Pabinger I
Hamostaseologie; 2015; 35(4):319-24. PubMed ID: 25740182
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment models for cancer-associated venous thromboembolism.
Dutia M; White RH; Wun T
Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
[TBL] [Abstract][Full Text] [Related]
16. Tests predictive of thrombosis in cancer.
Ay C; Pabinger I
Thromb Res; 2010 Apr; 125 Suppl 2():S12-5. PubMed ID: 20433990
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification strategies for cancer-associated thrombosis: an update.
Khorana AA; McCrae KR
Thromb Res; 2014 May; 133 Suppl 2():S35-8. PubMed ID: 24862143
[TBL] [Abstract][Full Text] [Related]
19. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
